Drugs by Class | Properties | Initial Dose | Dosage Range (mg) |
---|---|---|---|
β-Adrenergic Antagonists | |||
Atenolol | Selective | 50 mg PO daily | 25-100 |
Betaxolol | Selective | 10 mg PO daily | 5-40 |
Bisoprolol | Selective | 5 mg PO daily | 2.5-20 |
Metoprolol | Selective | 50 mg PO bid | 50-450 |
Metoprolol XL | Selective | 50-100 mg PO daily | 50-400 |
Nebivolol | Selective with vasodilatory properties | 5 mg PO daily | 5-40 |
Nadolol | Nonselective | 40 mg PO daily | 20-240 |
Propranolol | Nonselective | 40 mg PO bid | 40-240 |
Propranolol LA | Nonselective | 80 mg PO daily | 60-240 |
Timolol | Nonselective | 10 mg PO bid | 20-40 |
Pindolol | ISA | 5 mg PO daily | 10-60 |
Labetalol | α- and β-antagonist properties | 100 mg PO bid | 200-1200 |
Carvedilol | α- and β-antagonist properties | 6.25 mg PO bid | 12.5-50 |
Carvedilol CR | α- and β-antagonist properties | 10 mg PO daily | 10-80 |
Acebutolol | ISA, selective | 200 mg PO bid, 400 mg PO daily | 200-1200 |
Calcium Channel Antagonists | |||
Amlodipine | DHP | 5 mg PO daily | 2.5-10 |
Diltiazem | 30 mg PO qid | 90-360 | |
Diltiazem LA | 180 mg PO daily | 120-540 | |
Diltiazem CD | 180 mg PO daily | 120-480 | |
Diltiazem XR | 180 mg PO daily | 120-540 | |
Diltiazem XT | 180 mg PO daily | 120-480 | |
Isradipine | DHP | 2.5 mg PO bid | 2.5-10 |
Nicardipine | DHP | 20 mg PO tid | 60-120 |
Nifedipine | DHP | 10 mg PO tid | 30-120 |
Nifedipine XL (or CC) | DHP | 30 mg PO daily | 30-90 |
Nisoldipine | DHP | 20 mg PO daily | 20-40 |
Verapamil | 80 mg PO tid | 80-480 | |
Verapamil SR | 120 mg PO daily | 120-480 | |
Angiotensin-Converting Enzyme Inhibitors | |||
Benazepril | 10 mg PO bid | 10-40 | |
Captopril | 25 mg PO bid-tid | 50-450 | |
Enalapril | 5 mg PO daily | 2.5-40 | |
Fosinopril | 10 mg PO daily | 10-40 | |
Lisinopril | 10 mg PO daily | 5-40 | |
Moexipril | 7.5 mg PO daily | 7.5-30 | |
Quinapril | 10 mg PO daily | 5-80 | |
Ramipril | 2.5 mg PO daily | 1.25-20 | |
Trandolapril | 1-2 mg PO daily | 1-4 | |
Perindopril | 4 mg PO daily | 2-16 | |
Angiotensin II Receptor Blockers | |||
Azilsartan | 40 mg PO daily | 40-80 | |
Candesartan | 8 mg PO daily | 8-32 | |
Eprosartan | 600 mg PO daily | 600-800 | |
Irbesartan | 150 mg PO daily | 150-300 | |
Olmesartan | 20 mg PO daily | 20-40 | |
Losartan | 50 mg PO daily | 25-100 | |
Telmisartan | 40 mg PO daily | 20-80 | |
Valsartan | 80 mg PO daily | 80-320 | |
Direct Renin Inhibitors | |||
Aliskiren | 150 mg PO daily | 150-300 | |
Diuretics | |||
Chlorthalidone | Thiazide diuretic | 25 mg PO daily | 12.5-50 |
Hydrochlorothiazide | Thiazide diuretic | 12.5 mg PO daily | 12.5-50 |
Hydroflumethiazide | Thiazide diuretic | 50 mg PO daily | 50-100 |
Indapamide | Thiazide diuretic | 1.25 mg PO daily | 2.5-5 |
Methyclothiazide | Thiazide diuretic | 2.5 mg PO daily | 2.5-5 |
Metolazone | Thiazide diuretic | 2.5 mg PO daily | 1.25-5 |
Bumetanide | Loop diuretic | 0.5 mg PO daily (or IV) | 0.5-5 |
Ethacrynic acid | Loop diuretic | 50 mg PO daily (or IV) | 25-100 |
Furosemide | Loop diuretic | 20 mg PO daily (or IV) | 20-320 |
Torsemide | Loop diuretic | 5 mg PO daily (or IV) | 5-10 |
Amiloride | Potassium-sparing diuretic | 5 mg PO daily | 5-10 |
Triamterene | Potassium-sparing diuretic | 50 mg PO bid | 50-200 |
Eplerenone | Aldosterone antagonist | 25 mg PO daily | 25-100 |
Spironolactone | Aldosterone antagonist | 25 mg PO daily | 25-100 |
α-Adrenergic Antagonists | |||
Doxazosin | 1 mg PO daily | 1-16 | |
Prazosin | 1 mg PO bid-tid | 1-20 | |
Terazosin | 1 mg PO at bedtime | 1-20 | |
Centrally Acting Adrenergic Agents | |||
Clonidine | 0.1 mg PO bid | 0.1-1.2 | |
Clonidine patch | TTS 1/wk (equivalent to 0.1 mg/d release) | 0.1-0.3 | |
Guanfacine | 1 mg PO daily | 1-3 | |
Guanabenz | 4 mg PO bid | 1-64 | |
Methyldopa | 250 mg PO bid-tid | 250-2000 | |
Direct-Acting Vasodilators | |||
Hydralazine | 10 mg PO qid | 50-300 | |
Minoxidil | 5 mg PO daily | 2.5-100 | |
Miscellaneous | |||
Reserpine | 0.5 mg PO daily | 0.01-0.25 |
Drug | Administration | Onset | Duration of Action | Dosage | Adverse Effects and Comments |
---|---|---|---|---|---|
Fenoldopam | IV infusion | <5 min | 30 min | 0.1-0.3 µg/kg/min | Tachycardia, nausea, vomiting |
Sodium nitroprusside | IV infusion | Immediate | 2-3 min | 0.5-10 µg/kg/min (initial dose, 0.25 µg/kg/min for eclampsia and renal insufficiency) | Hypotension, nausea, vomiting, apprehension; risk of thiocyanate and cyanide toxicity is increased in renal and hepatic insufficiency, respectively; levels should be monitored; must shield from light |
Diazoxide | IV bolus | 15 min | 6-12 h | 50-100 mg q5-10min, up to 600 mg | Hypotension, tachycardia, nausea, vomiting, fluid retention, hyperglycemia; may exacerbate myocardial ischemia, heart failure, or aortic dissection |
Labetalol | IV bolus IV infusion | 5-10 min | 3-6 h | 20-80 mg q5-10min, up to 300 mg 0.5-2 mg/min | Hypotension, heart block, heart failure, bronchospasm, nausea, vomiting, scalp tingling, paradoxical pressor response; may not be effective in patients receiving α- or β-antagonists |
Nitroglycerin | IV infusion | 1-2 min | 3-5 min | 5-250 µg/min | Headache, nausea, vomiting. Tolerance may develop with prolonged use. |
Esmolol | IV bolus IV infusion | 1-5 min | 10 min | 500 µg/kg/min for first 1 min 50-300 µg/kg/min | Hypotension, heart block, heart failure, bronchospasm |
Phentolamine | IV bolus | 1-2 min | 3-10 min | 5-10 mg q5-15min | Hypotension, tachycardia, headache, angina, paradoxical pressor response |
Hydralazine (for treatment of eclampsia) | IV bolus | 10-20 min | 3-6 h | 10-20 mg q20min (if no effect after 20 mg, try another agent) | Hypotension, fetal distress, tachycardia, headache, nausea, vomiting, local thrombophlebitis. Infusion site should be changed after 12 h. |
Methyldopate (for treatment of eclampsia) | IV bolus | 30-60 min | 10-16 h | 250-500 mg | Hypotension |
Nicardipine | IV infusion | 1-5 min | 3-6 h | 5 mg/h, increased by 1.0-2.5 mg/h q15min, up to 15 mg/h | Hypotension, headache, tachycardia, nausea, vomiting |
Enalaprilat | IV bolus | 5-15 min | 1-6 h | 0.6255 mg q6h | Hypotension |